title: Complete remission of AIDS/Kaposi's sarcoma after treatment with a combination of two nucleoside reverse transcriptase inhibitors and one non-nucleoside reverse transcriptase inhibitor.
authors.forename: Guiseppe
authors.initials: G
authors.lastname: Murdaca
authors.forename: Antonio
authors.initials: A
authors.lastname: Campelli
authors.forename: Maurizio
authors.initials: M
authors.lastname: Setti
authors.forename: Francesco
authors.initials: F
authors.lastname: Indiveri
authors.forename: Francesco
authors.initials: F
authors.lastname: Puppo
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy* / Q000276:immunology / Q000821:virology; D000328:Adult; D000480:Alkynes; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active; D048588:Benzoxazines; D018791:CD4 Lymphocyte Count; D003521:Cyclopropanes; D015497:HIV-1 / Q000187:drug effects* / Q000235:genetics; D018451:Homosexuality, Male; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use*; D008297:Male; D009705:Nucleosides / Q000627:therapeutic use; D010078:Oxazines / Q000627:therapeutic use*; D012367:RNA, Viral / Q000097:blood; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*; D012514:Sarcoma, Kaposi / Q000188:drug therapy* / Q000276:immunology / Q000821:virology; D016896:Treatment Outcome; D019562:Viral Load; D015215:Zidovudine / Q000627:therapeutic use*
chemical_list: D000480:Alkynes; D019380:Anti-HIV Agents; D048588:Benzoxazines; D003521:Cyclopropanes; D009705:Nucleosides; D010078:Oxazines; D012367:RNA, Viral; D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine; D015215:Zidovudine; C098320:efavirenz